Compare United Airlines Holdings Inc (UAL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Airlines Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? United Airlines Holdings Inc trades at $126 (market cap $41.00B), while State Street SPDR S&P Biotech ETF trades at $159.49. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| UAL | XBI | |
|---|---|---|
Market Cap | $41.00B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $136.11 | $164.28 |
52-Week Low | $85.21 | $86.92 |
Enterprise Value | $58.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
United Airlines (UAL) trades at $125.37, up 1.3% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 11.83 and robust ROE of 23.25%. Recent earnings have consistently beaten estimates, and revenue is projected to grow to $62.9B in 2026. Analyst sentiment is overwhelmingly positive with a $167.73 consensus price target and no sell ratings.
The outlook for UAL is favorable due to solid earnings momentum and improving debt metrics, though risks include fuel cost volatility and execution of fleet innovation. The stock presents a value opportunity with upside potential, supported by strong institutional buy-in and manageable liabilities.
XBI trades at $158.81, up 0.49% today, with a bullish technical signal supported by moving averages. The ETF shows strong momentum with a 17% monthly gain and 75% annual return, driven by biotech sector strength. Analyst coverage is limited to one hold rating, while recent news highlights institutional buying interest and positive sector developments including M&A activity and drug trial successes.
The outlook remains positive given biotech's breakout from multi-year bear markets, though elevated volatility and policy risks persist. Key opportunities include AI-driven drug discovery and sustained M&A momentum, while risks involve sector-specific volatility and regulatory uncertainty. The ETF's equal-weight approach provides diversified exposure to biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
